➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Merck
Boehringer Ingelheim
AstraZeneca
McKinsey

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DEMADEX

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Demadex

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00602303 Bioequivalency Study of Torsemide Tablets Under Fasting Conditions Completed Roxane Laboratories N/A 2003-09-01 The objective of this study was the bioequivalence of a Roxane Laboratories' Torsemide Tablets, 20 mg, to Demadex® Tablets, 20 mg (Roche) under fasting conditions using a single-dose, 2-treatment, 2-period, crossover design.
NCT00602615 Bioequivalency Study of Torsemide Tablets Under Fed Conditions Completed Roxane Laboratories N/A 2003-09-01 The objective of this study was the bioequivalence of a Roxane Laboratories' Torsemide Tablets, 20 mg, to Demadex® Tablets, 20 mg (Roche) under fed conditions using a single-dose, 2-treatment, 2-period, crossover design.
NCT00653549 Bioavailability Study of Torsemide Tablets Under Fasting Conditions Completed Anapharm Phase 1 2001-04-01 To compare the single-dose bioavailability of Torsemide tablets with Demadex
NCT00653549 Bioavailability Study of Torsemide Tablets Under Fasting Conditions Completed Par Pharmaceutical, Inc. Phase 1 2001-04-01 To compare the single-dose bioavailability of Torsemide tablets with Demadex
NCT00654043 Bioavailability Study of Torsemide Tablets Under Fed Conditions Completed Anapharm Phase 1 2001-04-01 To compare the single-dose bioavailability of Torsemide tablets with Demadex
NCT00654043 Bioavailability Study of Torsemide Tablets Under Fed Conditions Completed Par Pharmaceutical, Inc. Phase 1 2001-04-01 To compare the single-dose bioavailability of Torsemide tablets with Demadex
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Demadex

Condition Name

Condition Name for Demadex
Intervention Trials
Edema 2
Congestive Heart Failure 1
Chronic Kidney Diseases 1
Body Weight Changes 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Demadex
Intervention Trials
Heart Failure 2
Renal Insufficiency, Chronic 1
Kidney Diseases 1
Malnutrition 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Demadex

Trials by Country

Trials by Country for Demadex
Location Trials
India 2
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Demadex
Location Trials
Missouri 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Demadex

Clinical Trial Phase

Clinical Trial Phase for Demadex
Clinical Trial Phase Trials
Phase 1 4
N/A 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Demadex
Clinical Trial Phase Trials
Completed 4
Not yet recruiting 2
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Demadex

Sponsor Name

Sponsor Name for Demadex
Sponsor Trials
Sarfez Pharmaceuticals, Inc. 2
Par Pharmaceutical, Inc. 2
Anapharm 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Demadex
Sponsor Trials
Industry 8
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Moodys
AstraZeneca
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.